Epilepsy Etiology
There is evidence suggesting that alterations in astrocyte chloride homeostasis may contribute to the development and maintenance of epileptic activity. The excitatory and inhibitory neurotransmission in the brain involve the release of neurotransmitters such as glutamate (excitatory) and GABA (gamma-aminobutyric acid, inhibitory). Changes in the concentration of chloride ions can affect the efficacy of GABAergic neurotransmission, as the direction and strength of the GABAergic response depend on the intracellular chloride concentration.
In some cases of epilepsy, it has been observed that the expression or function of the NKCC1 cotransporter in astrocytes and neurons may be altered. The NKCC1 cotransporter is responsible for importing chloride ions into cells, and increased activity of NKCC1 can result in elevated intracellular chloride levels. This, in turn, can lead to a shift in the GABAergic response from inhibitory to excitatory, a phenomenon known as “GABAergic depolarization.”
GABAergic depolarization can contribute to hyperexcitability in the brain, potentially facilitating the generation and propagation of epileptic seizures. Astrocytes may modulate the expression and function of NKCC1, influencing chloride homeostasis and, consequently, the balance between excitatory and inhibitory neurotransmission 1)
see Epileptogenesis.
symptomatic (AKA “secondary”): seizures of known etiology (e.g. stroke, tumor…)
2. idiopathic (AKA “primary”): no underlying cause. Includes:
a) juvenile myoclonic epilepsy
3. cryptogenic: seizures presumed to be symptomatic but with unknown etiology
a) West syndrome (infantile spasms, Blitz-Nick-Salaam Krämpfe)
4. special syndromes: situation-related seizures
b) seizures occurring only with acute metabolic or toxic events: e.g. alcohol
Benzodiazepines increases the activity of seizure foci which may be used for mapping foci during seizure surgery but may also induce seizures
Tumor-related
Seizures may be manifestation of intracranial tumor (IT) and demand thorough neurological evaluation. Tumor histology does not seem to affect seizure predisposition. Most seizures associated with IT occur in fifth and sixth decades of life and affect frontal lobe most often 2).
Thery are a common symptom in patients with Low-grade glioma (LGG), negatively influencing quality of life, if uncontrolled.
Seizures are the most frequent and often the only manifestation in patients with brain tumors of glial origin, and medical treatment appears to be less effective for seizure control because of incomplete understanding of underlying pathophysiological mechanisms. Particularly, patients with slow-growing low-grade tumors (low-grade gliomas (LGGs) and glioneuronal tumors) in cortical areas of the temporal lobe are more frequently associated with seizures than high-grade tumors 3) 4) 5).
Clinically, tumor-related seizures manifest as simple or complex partial seizures with or without secondary generalization and, in more than 50% of cases, are pharmacoresistant. When uncontrolled, tumor-related epilepsy affects patients' quality of life, causes cognitive deterioration, and may result in significant morbidity 6) 7).
Seizures during status epilepticus (SE) cause neuronal death and induce cyclooxygenase-2 (COX-2).
Traumatic brain injury (TBI)
Seizures may cause diagnostic confusion and be a source of metabolic stress after Pediatric traumatic brain injury. The incidence of electroencephalography (EEG)-confirmed seizures and of subclinical seizures in the pediatric population with TBI is not well known.
Seizure after aneurysmal subarachnoid hemorrhage
see Seizure after aneurysmal subarachnoid hemorrhage.
see Epilepsy in cerebral arteriovenous malformation.